Join the 'Parkinson's Disease' group to help and get support from people like you.

Parkinson's Disease Blog

Related terms: Parkinson's

Study Underscores Power of Placebo Effect

Posted 2 days 23 hours ago by Drugs.com

WEDNESDAY, Jan. 28, 2015 – A new study – this one involving patients with Parkinson's disease – adds another layer of insight to the well-known "placebo effect." That's the phenomenon in which people's symptoms improve after taking an inactive substance simply because they believe the treatment will work. The small study, involving 12 people, suggests that Parkinson's patients seem to feel better – and their brains may actually change – if they think they're taking a costly medication. On average, patients had bigger short-term improvements in symptoms like tremor and muscle stiffness when they were told they were getting the costlier of two drugs. In reality, both "drugs" were nothing more than saline, given by injection. But the study patients were told that one drug was a new medication priced at $1,500 a dose, while the other cost just $100 – though, the researchers assured ... Read more

Related support groups: Parkinson's Disease, Levodopa, Larodopa, Dopar

FDA Approves Duopa (carbidopa and levodopa) Enteral Suspension for Parkinson's Disease

Posted 19 days ago by Drugs.com

NORTH CHICAGO, Ill., Jan. 12, 2015 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved AbbVie's (NYSE: ABBV) Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease. DUOPA is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube. Duopa was approved by the FDA as an orphan drug, a designation granted to products intended for the treatment of rare diseases or conditions affecting fewer than 200,000 patients in the U.S. "There is unmet need for treatment options for patients with advanced Parkinson's disease. As the disease advances, it can be difficult to control motor features," said C. Warren Olanow, M.D., Professor, Department of Neurology and Department of ... Read more

Related support groups: Parkinson's Disease, Carbidopa/Levodopa

Impax Pharmaceuticals Announce FDA Approval of Rytary (carbidopa and levodopa) for Parkinson's Disease

Posted 19 days ago by Drugs.com

HAYWARD, Calif., Jan. 8, 2015 /PRNewswire/ – Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S. Food and Drug Administration (FDA) approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication. Rytary is not for use in patients using nonselective monoamine oxidase inhibitors (MAO) inhibitors. "The FDA approval of Rytary (pronounced rye-TAR-ee) is an important new development for the treatment of Parkinson's disease and provides an extended-release carbidopa-levodopa product that treats Parkinson's disease," said Fred Wilkinson, president and CEO, Impax Laboratories. "Rytary is designed to address one of the most significant unmet needs for ... Read more

Related support groups: Parkinson's Disease, Carbidopa/Levodopa

Exercise May Cut Fall Risk for Some Parkinson's Patients

Posted 5 Jan 2015 by Drugs.com

WEDNESDAY, Dec. 31, 2014 – Exercises that focus on balance and leg strengthening may help some people with Parkinson's disease avoid falls, according to a new clinical trial. The study, reported online Dec. 31 in Neurology, found that the benefits were limited to people with milder Parkinson's symptoms. The exercise program – done mostly at home – cut their risk of falling by about 70 percent over six months. But experts said that doesn't mean exercise is no help to people with more advanced Parkinson's. It's possible they may need an exercise program with more supervision, said lead researcher Colleen Canning, an associate professor at the University of Sydney in Australia. That possibility still needs to be studied, Canning added. But what seems clear, she said, is that "one size does not fit all" when it comes to exercise therapy for Parkinson's. Parkinson's disease is a chronic ... Read more

Related support groups: Parkinson's Disease, Prevention of Falls

Methamphetamine Use Linked to Parkinson's Risk

Posted 29 Dec 2014 by Drugs.com

FRIDAY, Dec. 26, 2014 – People who use methamphetamine have a greatly increased risk of developing Parkinson's disease, a new study warns. Researchers analyzed the medical records of more than 40,000 people in Utah. About 5,000 of that group were methamphetamine – or "meth" – users. Around 1,800 were cocaine users, and about 34,000 didn't use drugs, according to the researchers. The study found that methamphetamine users were three times more likely to develop Parkinson's disease. Cocaine users didn't have an increased risk of Parkinson's, the researchers said. The study wasn't designed to prove that methamphetamine caused Parkinson's disease, but it did find a strong association between use of the drug and the development of the disorder. The study was published recently in the journal Drug and Alcohol Dependence. The researchers also found that women who use methamphetamine appear ... Read more

Related support groups: Parkinson's Disease, Methamphetamine, Desoxyn, Desoxyn Gradumet

Daily Physical Activity May Help Lower Parkinson's Risk

Posted 25 Nov 2014 by Drugs.com

TUESDAY, Nov. 25, 2014 – A moderate amount of physical activity in your daily life may reduce your risk of Parkinson's disease, according to a new study. "We found that a medium level of daily total physical activity is associated with a lower risk of Parkinson's disease," study author Karin Wirdefeldt, of the Karolinska Institute in Stockholm, said in a news release from the journal that published her study, Brain: A Journal of Neurology. While the study found a link between exercise and a reduced risk of Parkinson's disease, it's important to note that it wasn't designed to prove that exercise was the definitive cause of this lower risk. The research included more than 43,000 women and men in Sweden who were followed for an average of more than 12 years. None had Parkinson's disease when they enrolled. Nearly 300 had been diagnosed with the disorder by the end of the study. Those who ... Read more

Related support groups: Parkinson's Disease

Parkinson's Drugs May Spur Compulsive Behaviors

Posted 20 Oct 2014 by Drugs.com

MONDAY, Oct. 20, 2014 – Drugs commonly used to treat Parkinson's disease may raise the risk of so-called impulse control disorders, according to a new review. These disorders include compulsive gambling, compulsive shopping and/or hypersexuality. That increased risk was seen in a fresh review of a decade's worth of U.S. Food and Drug Administration (FDA) records. "What we have here is a striking example of a major problem in drug safety," said study author Thomas Moore, a senior scientist with the Institute of Safe Medication Practices and a lecturer in epidemiology and biostatistics at George Washington University, in Washington, D.C. "And that is the issue of how drugs can sometimes provoke psychiatric side effects that actually make people behave in extremely destructive and abnormal ways." Moore and his colleagues reported their findings online Oct. 20 in the journal JAMA Internal ... Read more

Related support groups: Parkinson's Disease, Mirapex, Requip, Ropinirole, Pramipexole, Neupro, Requip XL, Rotigotine, Apokyn, Mirapex ER, Repreve, APO-Go, Uprima, Apomorphine, Requip Starter Kit, APO-Go Pen, ReQuip Follow on Pack, ReQuip Starter Pack

Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later?

Posted 17 Sep 2014 by Drugs.com

WEDNESDAY, Sept. 17, 2014 – Migraines in midlife may be associated with increased odds of developing Parkinson's disease or other movement disorders in later years, new research suggests. The study, which did not prove a cause-and-effect link between the two brain-based conditions, also suggested that the migraine-Parkinson's association was stronger in women with migraines preceded by aura. An aura is a warning sign of a pending attack that includes flashes of light and skin tingling. "We should emphasize that while the risk is increased for Parkinson's disease and these [similar] symptoms, they're still uncommon among those with migraine," said study author Ann Scher, a professor of epidemiology at Uniformed Services University in Bethesda, Md. "I don't think people should necessarily worry that if they have migraines, Parkinson's disease is [in their future]." The research is ... Read more

Related support groups: Migraine, Parkinson's Disease

Deep Brain Stimulation Safe for Older Parkinson's Patients: Study

Posted 26 Aug 2014 by Drugs.com

TUESDAY, Aug. 26, 2014 – The risk of complications when implanting deep brain stimulation devices in the brains of people with Parkinson's disease is no greater in older patients than younger ones, a new study shows. The treatment involves placing electrodes in specific parts of the brain. The new findings should ease concerns about using the devices in patients older than 75, the Duke University researchers said. They analyzed data from more than 1,750 Parkinson's patients who had the devices implanted between 2000 and 2009. Of those patients, 7.5 percent had at least one complication within 90 days of the surgery. Complications included wound infections, bleeding, pneumonia and pulmonary embolism. However, the overall risk of complications did not significantly increase with age, the researchers reported Aug. 25 in the journal JAMA Neurology. Older patients were more likely to ... Read more

Related support groups: Parkinson's Disease

Robin Williams Had Early Stage Parkinson's Disease, Wife Reveals

Posted 15 Aug 2014 by Drugs.com

FRIDAY, Aug. 15, 2014 – Robin Williams was diagnosed with Parkinson's disease before he committed suicide this week, and he was sober at the time of his death, his wife announced Thursday afternoon. In a prepared statement, Susan Schneider said her husband continued his decades-long battle against depression and anxiety, and he was in the early stages of Parkinson's when he was found dead at his suburban San Francisco home on Monday. Schneider said her husband, the celebrated Oscar-winning actor and comedian, wasn't prepared to publicly share his Parkinson's diagnosis. "Robin's sobriety was intact and he was brave as he struggled with his own battles of depression [and] anxiety as well as early stages of Parkinson's disease, which he was not yet ready to share publicly," Schneider said. "It is our hope in the wake of Robin's tragic passing that others will find the strength to seek the ... Read more

Related support groups: Parkinson's Disease

Robin Williams Had Parkinson's Disease, Wife Says

Posted 14 Aug 2014 by Drugs.com

THURSDAY, Aug. 14, 2014 – Robin Williams was diagnosed with Parkinson's disease before he committed suicide this week, and he was sober at the time of his death, his wife announced Thursday afternoon. In a prepared statement, Susan Schneider said her husband continued his decades-long battle with depression and anxiety, and he was in the early stages of Parkinson's when he was found dead at his suburban San Francisco home on Monday. Schneider said her husband, the celebrated Oscar-winning actor and comedian, wasn't prepared to publicly share his Parkinson's diagnosis. "Robin's sobriety was intact and he was brave as he struggled with his own battles of depression [and] anxiety as well as early stages of Parkinson's disease, which he was not yet ready to share publicly," Schneider said, according to published reports. "It is our hope in the wake of Robin's tragic passing that others ... Read more

Related support groups: Parkinson's Disease, Parkinsonism, Parkinsonian Tremor

Brisk Walking May Help Curb Parkinson's Symptoms

Posted 3 Jul 2014 by Drugs.com

WEDNESDAY, July 2, 2014 – People with Parkinson's disease who regularly walk for exercise may significantly improve their physical and mental function, a new study finds. "The benefits of exercise that apply to a normal, healthy person are even greater in Parkinson's disease because it also affects the symptoms of the disease. A person with Parkinson's will get all the benefits that a normal, healthy person does, plus it will modify the symptoms of their disease," said Dr. Daniel Corcos, a professor of physical therapy and human movement sciences at Northwestern University in Chicago. Corcos was not involved in the new study. Parkinson's is a motor system disorder that impairs a person's ability to control their muscle movements. The new study, published online July 2 in the journal Neurology, involved 60 Parkinson's disease patients between the ages of 50 and 80. All were in the early ... Read more

Related support groups: Parkinson's Disease

MRI Technique May Help Detect Parkinson's Earlier

Posted 12 Jun 2014 by Drugs.com

THURSDAY, June 12, 2014 – A simple and quick MRI technique might aid in early detection of Parkinson's disease, British researchers report. The new MRI approach can detect with 85 percent accuracy people who have early stage Parkinson's disease, according to findings published online June 11 in the journal Neurology. That's important because the early symptoms of Parkinson's are subtle, which makes an accurate early stage diagnosis very difficult, the researchers said. This new test, which focuses on scans of a part of the brain known as the basal ganglia, could improve the lives of countless patients with Parkinson's, said senior author Clare Mackay, a senior research fellow with the Oxford Parkinson's Disease Center at Oxford University. "By the time symptoms of Parkinson's are obvious, a lot of damage has already taken place in the brain," Mackay said. "To reduce the impact of ... Read more

Related support groups: Parkinson's Disease, Diagnosis and Investigation, CNS Magnetic Resonance Imaging

FDA Approves Expanded Label for Azilect for Treatment Across All Stages of Parkinson’s Disease

Posted 11 Jun 2014 by Drugs.com

JERUSALEM--(BUSINESS WIRE)--Jun. 9, 2014-- Teva Pharmaceutical Industries Ltd. today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Azilect (rasagiline tablets) from monotherapy and adjunct to levodopa (LD) to now include adjunct to dopamine agonists (DAs). The new indication reflects that Azilect can be used alone or in combination with other Parkinson’s disease (PD) medications. The approval reinforces the growing clinical evidence demonstrating the benefit of Azilect across all stages of PD. “The FDA approval of the expanded label for Azilect will be a welcome addition in the treatment of PD,” said Michael Hayden, M.D., Ph.D., President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical Industries Ltd. “Teva continues its commitment to those living with PD and to research in areas of neurodegenerative diseases to develop solutio ... Read more

Related support groups: Parkinson's Disease, Azilect, Rasagiline

Levodopa May Beat Newer Meds for Long-Term Parkinson's Care: Study

Posted 11 Jun 2014 by Drugs.com

WEDNESDAY, June 11, 2014 – When it comes to which drug works best for patients with newly diagnosed Parkinson's disease, older may still be better, a new study finds. Research published June 10 in The Lancet finds that the dopamine drug levodopa still outperforms newer medications for the long-term care of people newly diagnosed with Parkinson's. "This study lays to rest lingering questions among both people with Parkinson's disease and their doctors about which drug is most beneficial when first beginning treatment for the disease," said James Beck, vice president of scientific affairs at the Parkinson's Disease Foundation (PDF). In the largest-ever trial of Parkinson's disease treatment, levodopa offered patients better mobility and a higher quality of life than the two main alternatives – drugs called dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors. The study ... Read more

Related support groups: Parkinson's Disease, Sinemet, Levodopa, Stalevo, Sinemet CR, Carbidopa/Levodopa, Stalevo 100, Parcopa, Stalevo 200, Stalevo 150, Dopar, Stalevo 50, Carbidopa/Entacapone/Levodopa, Atamet, Larodopa

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Parkinsonian Tremor, Parkinsonism, Central Nervous System Disorders

Related Drug Support Groups

Mirapex, Requip, Sinemet, ropinirole, creatine, Cogentin, pramipexole, benztropine, bromocriptine, view more... Exelon, Azilect, levodopa, belladonna, selegiline, amantadine, Neupro, Parlodel, Artane, trihexyphenidyl, Stalevo, Requip XL, Comtan, Sinemet CR, carbidopa / levodopa, rivastigmine, Stalevo 100, entacapone, procyclidine, rasagiline, Eldepryl, Symmetrel, pergolide, Apokyn, rotigotine, Parcopa, Repreve, Belladonna Tincture, Mirapex ER, Stalevo 200, Requip Starter Kit, Uprima, Stalevo 150, APO-Go, Trihexane, Kemadrin, Akineton, Permax, apomorphine, Tasmar, APO-Go Pen, carbidopa / entacapone / levodopa, Trihexy, biperiden, Stalevo 50, tolcapone, Zelapar, Selgene, Jumex, Atapryl, Carbex, Larodopa, Atamet, Dopar, ReQuip Starter Pack, ReQuip Follow on Pack, Akineton HCl